Cargando…

Li-Fraumeni syndrome in the setting of re-occurring malignancies after 27 years of remission: a case report

Multiple primary tumors are defined as multiple simultaneous (within 6 months) or heterogeneous tumors. CASE PRESENTATION: Here, the authors present the case of a 58-year-old Saudi female patient with Li-Fraumeni syndrome who has multiple primary tumors. CLINICAL DISCUSSION: The surgical cytoreducti...

Descripción completa

Detalles Bibliográficos
Autores principales: Mousa, Ahmed H., Ibrahim, Abdullatif S., Alsayed, Abdelrahman Waleed, Albukhari, Zain Z., Mogharbel, Ajfan, Alshanberi, Asim M., Albar, Nezar Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289717/
https://www.ncbi.nlm.nih.gov/pubmed/37363471
http://dx.doi.org/10.1097/MS9.0000000000000724
_version_ 1785062340043997184
author Mousa, Ahmed H.
Ibrahim, Abdullatif S.
Alsayed, Abdelrahman Waleed
Albukhari, Zain Z.
Mogharbel, Ajfan
Alshanberi, Asim M.
Albar, Nezar Y.
author_facet Mousa, Ahmed H.
Ibrahim, Abdullatif S.
Alsayed, Abdelrahman Waleed
Albukhari, Zain Z.
Mogharbel, Ajfan
Alshanberi, Asim M.
Albar, Nezar Y.
author_sort Mousa, Ahmed H.
collection PubMed
description Multiple primary tumors are defined as multiple simultaneous (within 6 months) or heterogeneous tumors. CASE PRESENTATION: Here, the authors present the case of a 58-year-old Saudi female patient with Li-Fraumeni syndrome who has multiple primary tumors. CLINICAL DISCUSSION: The surgical cytoreduction or ‘debulking’ technique is the main treatment option started in individuals with High Grade Serous Ovarian CanceR. This surgical strategy aims to completely remove all disseminated tumor masses that are present in the patient’s peritoneal cavity on a macroscopic level. CONCLUSION: In conclusion, in our case, she has developed her ovarian cancer 27 years after her breast cancer got treated. This was already stage IIIB to stage IV. If it was not for her incidental discovery of her urinary bladder cancer, which is most likely is a long-term sequel of using cyclophosphamide 27 years ago. Multiple primary tumors are defined as multiple simultaneous (within 6 months) or heterogeneous tumors. Here, the authors present the case of a 58-year-old Saudi female patient with Li-Fraumeni syndrome who has multiple primary tumors. In conclusion, in our case, she has developed her ovarian cancer 27 years after her breast cancer got treated. This was already stage IIIB to stage IV. If it was not for her incidental discovery of her urinary bladder cancer, which is most likely is a long-term sequel of using cyclophosphamide 27 years ago.
format Online
Article
Text
id pubmed-10289717
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-102897172023-06-24 Li-Fraumeni syndrome in the setting of re-occurring malignancies after 27 years of remission: a case report Mousa, Ahmed H. Ibrahim, Abdullatif S. Alsayed, Abdelrahman Waleed Albukhari, Zain Z. Mogharbel, Ajfan Alshanberi, Asim M. Albar, Nezar Y. Ann Med Surg (Lond) Case Reports Multiple primary tumors are defined as multiple simultaneous (within 6 months) or heterogeneous tumors. CASE PRESENTATION: Here, the authors present the case of a 58-year-old Saudi female patient with Li-Fraumeni syndrome who has multiple primary tumors. CLINICAL DISCUSSION: The surgical cytoreduction or ‘debulking’ technique is the main treatment option started in individuals with High Grade Serous Ovarian CanceR. This surgical strategy aims to completely remove all disseminated tumor masses that are present in the patient’s peritoneal cavity on a macroscopic level. CONCLUSION: In conclusion, in our case, she has developed her ovarian cancer 27 years after her breast cancer got treated. This was already stage IIIB to stage IV. If it was not for her incidental discovery of her urinary bladder cancer, which is most likely is a long-term sequel of using cyclophosphamide 27 years ago. Multiple primary tumors are defined as multiple simultaneous (within 6 months) or heterogeneous tumors. Here, the authors present the case of a 58-year-old Saudi female patient with Li-Fraumeni syndrome who has multiple primary tumors. In conclusion, in our case, she has developed her ovarian cancer 27 years after her breast cancer got treated. This was already stage IIIB to stage IV. If it was not for her incidental discovery of her urinary bladder cancer, which is most likely is a long-term sequel of using cyclophosphamide 27 years ago. Lippincott Williams & Wilkins 2023-04-27 /pmc/articles/PMC10289717/ /pubmed/37363471 http://dx.doi.org/10.1097/MS9.0000000000000724 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Case Reports
Mousa, Ahmed H.
Ibrahim, Abdullatif S.
Alsayed, Abdelrahman Waleed
Albukhari, Zain Z.
Mogharbel, Ajfan
Alshanberi, Asim M.
Albar, Nezar Y.
Li-Fraumeni syndrome in the setting of re-occurring malignancies after 27 years of remission: a case report
title Li-Fraumeni syndrome in the setting of re-occurring malignancies after 27 years of remission: a case report
title_full Li-Fraumeni syndrome in the setting of re-occurring malignancies after 27 years of remission: a case report
title_fullStr Li-Fraumeni syndrome in the setting of re-occurring malignancies after 27 years of remission: a case report
title_full_unstemmed Li-Fraumeni syndrome in the setting of re-occurring malignancies after 27 years of remission: a case report
title_short Li-Fraumeni syndrome in the setting of re-occurring malignancies after 27 years of remission: a case report
title_sort li-fraumeni syndrome in the setting of re-occurring malignancies after 27 years of remission: a case report
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289717/
https://www.ncbi.nlm.nih.gov/pubmed/37363471
http://dx.doi.org/10.1097/MS9.0000000000000724
work_keys_str_mv AT mousaahmedh lifraumenisyndromeinthesettingofreoccurringmalignanciesafter27yearsofremissionacasereport
AT ibrahimabdullatifs lifraumenisyndromeinthesettingofreoccurringmalignanciesafter27yearsofremissionacasereport
AT alsayedabdelrahmanwaleed lifraumenisyndromeinthesettingofreoccurringmalignanciesafter27yearsofremissionacasereport
AT albukharizainz lifraumenisyndromeinthesettingofreoccurringmalignanciesafter27yearsofremissionacasereport
AT mogharbelajfan lifraumenisyndromeinthesettingofreoccurringmalignanciesafter27yearsofremissionacasereport
AT alshanberiasimm lifraumenisyndromeinthesettingofreoccurringmalignanciesafter27yearsofremissionacasereport
AT albarnezary lifraumenisyndromeinthesettingofreoccurringmalignanciesafter27yearsofremissionacasereport